ABERNETHY MATT — SEC insider filings

SEC reporting owner CIK 1724097. 27 insider filings on record with FilingPulse; latest filed 2026-09-15.

Transaction summary — filings shown

Covers all 27 filings on record, filed 2020-08-07 to 2026-09-15. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
NEUROCRINE BIOSCIENCES INC (NBIX)Chief Financial Officer25—29 legs · 104,034 sh · $12,795,45546
FATE THERAPEUTICS INC (FATE)Director2——2

Insider filings — ABERNETHY MATT

FiledFormIssuerReported transactionsSource
2026-09-154NEUROCRINE BIOSCIENCES INC (NBIX)Grant/award (A): 5,020 @ $0 · Tax withholding (F): 2,709 @ $156.22 · Sale (S): 2,311 @ $157.20EDGAR
2026-06-154FATE THERAPEUTICS INC (FATE)Grant/award (A): 87,900 (derivative) @ $0EDGAR
2026-03-054NEUROCRINE BIOSCIENCES INC (NBIX)Gift (G): 2,249 @ $0EDGAR
2026-02-174NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 2,133 @ $0 · Tax withholding (F): 1,151 @ $123.10 · Option exercise (M): 2,241 @ $0 · Tax withholding (F): 1,210 @ $124.12 · Option exercise (M): 2,566 @ $0 · Tax withholding (F): 1,385 @ $124.12 · +7 moreEDGAR
2026-02-034NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 2,437 @ $0 · Tax withholding (F): 1,368 @ $136.06 · Option exercise (M): 2,437 (derivative) @ $0EDGAR
2025-05-304FATE THERAPEUTICS INC (FATE)Grant/award (A): 110,000 (derivative) @ $0EDGAR
2025-02-144NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 2,566 @ $0 · Sale (S): 1,352 @ $116.85 · Option exercise (M): 2,241 @ $0 · Sale (S): 1,206 @ $116.87 · Grant/award (A): 45,538 (derivative) @ $0 · Grant/award (A): 8,534 (derivative) @ $0 · +2 moreEDGAR
2025-02-124NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 1,860 @ $0 · Sale (S): 980 @ $118.27 · Option exercise (M): 1,860 (derivative) @ $0EDGAR
2025-02-044NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 2,436 @ $0 · Sale (S): 1,283 @ $152.87 · Option exercise (M): 2,436 (derivative) @ $0EDGAR
2024-08-154NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 14,100 @ $73.60 · Sale (S): 14,100 @ $150.38 · Option exercise (M): 14,100 (derivative) @ $0EDGAR
2024-07-184NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 900 @ $73.60 · Sale (S): 900 @ $150.04 · Option exercise (M): 900 (derivative) @ $0EDGAR
2024-05-164NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 15,000 @ $73.60 · Sale (S): 15,000 @ $135.66 · Option exercise (M): 15,000 @ $73.60 · Sale (S): 15,000 @ $140.24 · Option exercise (M): 15,000 (derivative) @ $73.60 · Option exercise (M): 15,000 (derivative) @ $73.60EDGAR
2024-02-154NEUROCRINE BIOSCIENCES INC (NBIX)Sale (S): 1,352 @ $132.85 · Grant/award (A): 45,058 (derivative) @ $0 · Grant/award (A): 8,966 (derivative) @ $0EDGAR
2024-02-084NEUROCRINE BIOSCIENCES INC (NBIX)Sale (S): 1,280 @ $142.19 · Sale (S): 980 @ $134.21EDGAR
2024-02-024NEUROCRINE BIOSCIENCES INC (NBIX)Sale (S): 1,283 @ $140.72EDGAR
2023-08-234NEUROCRINE BIOSCIENCES INC (NBIX)Sale (S): 2,132 @ $107.39EDGAR
2023-02-154NEUROCRINE BIOSCIENCES INC (NBIX)Grant/award (A): 63,789 (derivative) @ $0 · Grant/award (A): 10,264 (derivative) @ $0EDGAR
2023-02-084NEUROCRINE BIOSCIENCES INC (NBIX)Sale (S): 1,280 @ $105.67 · Sale (S): 2,030 @ $102.33 · Sale (S): 12,807 @ $102.42 · Sale (S): 11,491 @ $102.40 · Sale (S): 980 @ $104.19EDGAR
2023-02-024NEUROCRINE BIOSCIENCES INC (NBIX)Sale (S): 1,283 @ $109.98EDGAR
2022-02-094NEUROCRINE BIOSCIENCES INC (NBIX)Sale (S): 2,030 @ $80.80 · Sale (S): 1,280 @ $80.78 · Sale (S): 980 @ $79.65EDGAR
2022-02-024NEUROCRINE BIOSCIENCES INC (NBIX)Grant/award (A): 66,362 (derivative) @ $0 · Grant/award (A): 9,745 (derivative) @ $0EDGAR
2021-12-034NEUROCRINE BIOSCIENCES INC (NBIX)Sale (S): 1,645 @ $82.59EDGAR
2021-03-264/ANEUROCRINE BIOSCIENCES INC (NBIX)Grant/award (A): 49,049 (derivative) @ $0EDGAR
2021-02-094NEUROCRINE BIOSCIENCES INC (NBIX)Sale (S): 880 @ $116.85 · Sale (S): 2,030 @ $116.81 · Grant/award (A): 44,632 (derivative) @ $0 · Grant/award (A): 7,439 (derivative) @ $0EDGAR
2020-12-024NEUROCRINE BIOSCIENCES INC (NBIX)Sale (S): 1,645 @ $94.66EDGAR
2020-11-164NEUROCRINE BIOSCIENCES INC (NBIX)Sale (S): 2,257 @ $90.74EDGAR
2020-08-074NEUROCRINE BIOSCIENCES INC (NBIX)Sale (S): 2,257 @ $118.90EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-06 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1724097 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs